OXOLIFE is thrilled to announce that on Monday, July the 8th, our CEO, Agnès Arbat Arbat, will be presenting the abstract “Efficacy results from the phase II randomized clinical trial: OXO-001 in infertile women undergoing egg donation IVF/ICSI” at the 40th Annual European Society of Human Reproduction and Embryology (ESHRE) Meeting, in Amsterdam . This presentation has been selected as one of the most exciting pieces of research to be showcased at the meeting.
Session details:
– Session Code: 1060
– Session Title: Session 06: Therapeutic Concepts in Implantation and Early Pregnancy
– Time: 10:00 – 10:15
– Location: Park Foyer
We are excited about the opportunity to connect face-to-face with experts in reproductive medicine from around the world.
Looking forward to seeing you in Amsterdam